Enlight Energy — Director's Dealing 2026

May 28, 2026

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

☐ Check this box if no longer subject to Section 16, Form 4 or Form 5 obligations may continue. See Instruction 1(b).

☐ STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average	-
border hours	0.5
per response

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person* Goren Ilan	2. Issuer Name and Ticker or Trading Symbol Enlight Renewable Energy Ltd. [ENLT] 2a. Foreign Trading Symbol ENLT	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director X Officer (give title below) 10% Owner Other (specify below) GENERAL MANAGER, ENLIGHT US
(Last)	(First)	(Middle)
C/O ENLIGHT RENEWABLE ENERGY LTD. 13 AMAL ST. AFEK INDUSTRIAL PARK
(Street)		3. Date of Earliest Transaction (Month/Day/Year) 05/27/2026
ROSH HA'AYIN	4802949
(City)	(State)	(Zip/Postal Code)
ISRAEL
(Country)
Table I – Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
---	---	---
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)
Ordinary shares, NIS 0.1 par value per share	05/27/2026
Ordinary shares, NIS 0.1 par value per share	05/27/2026
Ordinary shares, NIS 0.1 par value per share	05/27/2026
Table II – Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
---	---	---
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)
Stock Options (right to buy)	$23.22(1)	05/27/2026
Stock Options (right to buy)	$22.17(6)
Stock Options	$27.33(9)

---

| (right to buy) | | | | | | | | | NIS 0.1
par
value
per
share | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

Explanation of Responses:

1. Represents an exercise price of NIS 71.89, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
2. Includes (i) 14,083 restricted share units granted on April 21, 2024, with 7,041 vesting on April 21, 2027 and 7,042 vesting on April 21, 2028; and (ii) 21,710 restricted share units granted on July 29, 2025, with 5,427 vesting on each of October 1, 2026 and October 1, 2028, and 5,428 vesting on each of October 1, 2027 and October 1, 2029. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.
3. These shares were retained by the Company in payment of the exercise price of the employee stock options exercised by the Reporting Person. The amount retained by the Company was not in excess of the amount of the exercise price.
4. Represents a transaction price of NIS 296.66, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.859 as of the date immediately preceding the date of the transaction.
5. Stock options were granted on September 30, 2021, with 35,000 having vested on September 30, 2024; and 30,000 having vested on September 30, 2025.
6. Represents an exercise price of NIS 68.64, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
7. Stock options were granted on June 28, 2022, with 25,000 having vested on each of June 28, 2023 and June 28, 2024; 35,000 having vested on June 28, 2025; and 15,000 vesting on June 28, 2026.
8. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
9. Represents an exercise price of NIS 84.60, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
10. Stock options were granted on July 29, 2025, with 24,685 vesting on October 1, 2026; and 24,686 vesting on each of October 1, 2027, October 1, 2028, and October 1, 2029.

By: /s/ Helit Megido as attorney-in-fact for Ilan Goren
05/28/2026
Signature of Reporting Person
Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

• If the form is filed by more than one reporting person, see Instruction 4(b)(v).
  ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.